Optiscan Imaging

Optiscan Imaging EBITDA Growth YoY

The Year-over-Year EBITDA Growth of Optiscan Imaging (OIL.AX) as of Oct 29, 2026 is -84.68 %. In the previous year, Year-over-Year EBITDA Growth was 26.84 % — a change of -415.49% (lower).

EBITDA Growth YoY

-84.68 %

YoY

-415.49%

Last updated:

Year-over-Year EBITDA Growth of Optiscan Imaging is 2026 -84.68 % . Year-over-Year EBITDA Growth of Optiscan Imaging was 2025 26.84 % . It decreases by -415.49% lower compared to the previous year.

The Optiscan Imaging EBITDA Growth YoY history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA Growth YoY
Date
EBITDA Growth YoY
Jan 1, 2019
-16.47 AUD
Jan 1, 2020
2.82 AUD
Jan 1, 2021
-60.64 AUD
Jan 1, 2022
-50.04 AUD
Jan 1, 2023
6.09 AUD
Jan 1, 2024
-59.85 AUD
Jan 1, 2025
26.84 AUD
Jan 1, 2026
-84.68 AUD
The Optiscan Imaging EBITDA Growth YoY history
YEAREBITDA Growth YoYYoY
-84.68 %-415.49%
26.84 %-144.84%
-59.85 %-1,083.07%
6.09 %-112.17%
-50.04 %-17.48%
-60.64 %-2,249.03%
2.82 %-117.13%
-16.47 %-132.91%
50.06 %-168.49%
-73.08 %-1,331.27%
5.94 %-214.42%
-5.19 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Optiscan Imaging Stock analysis

What does Optiscan Imaging do? Optiscan Imaging Ltd is an Australian company specializing in the development and commercialization of advanced imaging technologies. The company was founded in 1994 and is headquartered in Notting Hill, a suburb of Melbourne. Optiscan was originally established as a spin-off company from Monash University to enable the commercial application of a groundbreaking technology called confocal microscopy. However, over the years, the company has expanded into other imaging technologies and now offers a wide range of products and services. Optiscan's business model involves developing and bringing to market innovative technologies that can be used in biomedical research and clinical diagnostics. The company works closely with research institutions and companies in various industries to develop customized imaging solutions. Optiscan offers a wide range of products, including confocal microscopes, multiphotonic microscopes, real-time imaging systems, and Raman spectrometers. These products are used in various application areas such as cancer research, neurobiology, cell biology, and materials science. Another important area for Optiscan is veterinary imaging. The company has developed a product line for veterinary medicine that is used by veterinarians and researchers around the world. Optiscan's imaging systems enable veterinarians to obtain precise and detailed images of animals to enable better diagnosis and treatment. Optiscan also operates a service department that offers customized imaging solutions to customers. The company provides services such as image processing, data analysis, and prototype development. Overall, Optiscan has become one of the leading providers of imaging technologies in Australia and globally over the past decades. The company has a long history of collaboration with leading research institutions and companies worldwide and remains committed to developing innovative solutions for the challenges of biomedicine and imaging. Optiscan Imaging is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Optiscan Imaging stock

Year-over-Year EBITDA Growth of Optiscan Imaging is -84.68 % in 2026.

On Eulerpool you can find the complete historical development of Year-over-Year EBITDA Growth Optiscan Imaging since 2006 – with annual values, charts, and detailed analysis.

EBITDA growth measures the percentage change in EBITDA compared to the prior year. It shows changes in operating cash earnings before capital structure effects.

To evaluate Year-over-Year EBITDA Growth's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Year-over-Year EBITDA Growth.

Year-over-Year EBITDA Growth's is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Year-over-Year EBITDA Growth's Optiscan Imaging historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Growth — Optiscan Imaging

All Key Metrics — Optiscan Imaging